Tokyo, Feb. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060610) titled 'An Interview Study on the Burden and Impact on Daily Life Among Patients with Acute Myeloid Leukemia (AML)' on Feb. 6.
Study Type:
Observational
Primary Sponsor:
Institute - Fukushima Medical University
Condition:
Condition - Acute Myeloid Leukemia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the burden experienced by patients with relapsed/refractory acute myeloid leukemia (AML) in their daily lives, and the impact of AML on their daily activities.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - N...